Zhejiang Starry Pharmaceutical Company Ltd. manufactures medical drugs. The Company specializes in the production of pharmaceutical raw materials and intermediates for the production of fluoroquinolones.

Zhejiang Starry Pharmaceutical (603520 CH)

Announcement on Passing On-site Inspection by FDA

Announcement on Resolutions of the 13th Meeting of the 5th Board of Directors

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zhejiang Starry Pharmaceutical (603520 CH)

Announcement on Passing On-site Inspection by FDA

Announcement on Resolutions of the 13th Meeting of the 5th Board of Directors

Report for Q3 2024

Notice on Convening the 2nd Extraordinary General Meeting in 2024

Announcement on Amending the Articles of Association

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)